Enforcement Working Group

Today, nothing short of a global approach to inhibiting the flow of potentially deadly counterfeit medical products is required. Every country around the world suffers the same problems. The global trade in medicines and medical devices necessitates that countries actively work together and commit to reducing the international trade in counterfeit medical products.

Organised criminals trading in counterfeit medical products have well developed worldwide networks which do not recognise any borders between countries. Working with well informed law enforcement officers at a global level makes a difference, more importantly it will have a positive impact in your country.

By working with INTERPOL, World Customs Organization and an international network of enforcement officers such as the Permanent Forum on International Pharmaceutical Crime, IMPACT aims at improving contact and mutual understanding among enforcement officials of different countries in order to improve coordination of operations and rapid exchange of information. IMPACT is also a platform for enforcement officers to establish communication with health authorities and other stakeholders, including industry and health professionals to combat the trade in counterfeit medical products.

The Enforcement Working Group aims to:

  • develop advocacy materials to increase resources available for enforcement
  • promote multi-country initiatives to improve coordination and information exchange among enforcement institutions and officers;
  • develop projects aimed at improving communication and collaboration between regulatory and enforcement officers
  • develop training materials and manuals to improve skills of enforcement officers
  • Identify gaps in existing legislation, need for resources and propose solutions
Resources

For comments:

:: A guide to investigate counterfeit medical products and pharmaceutical crime, can be requested from the Secretariat.

Useful links
Share

Contact details

Co-Chairs Enforcement Working Group:
Ms Aline Plançon,
INTERPOL
Mr Eric McIntosh,
Therapeutic Goods Administration, Australia